Eli Lilly will acquire psychedelic drugmaker AtaiBeckley for $2.8 billion up front, the company said Thursday, as momentum grows for using versions of the drugs as mental health treatments.
Enter your account data and we will send you a link to reset your password.
Here you'll find all collections you've created before.